Modulation of Breast Cancer Risk Biomarkers in Postmenopausal Women by High Dose Omega-3 Fatty Acids.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Breast cancer
- Focus Biomarker; Pharmacodynamics
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2012 Planned end date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 23 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.